Validation of the NCCN prostate cancer favorable- and...

  • Main
  • 2019 / 12
  • Validation of the NCCN prostate cancer favorable- and...
Brachytherapy 2019 / 12

Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy

Tom, Martin C., Reddy, Chandana.A., Smile, Timothy D., Zhang, Ryan X., Ciezki, Jay P., Stephans, Kevin L., Mian, Omar Y., Klein, Eric A., Campbell, Steven, Ulchaker, James, Angermeier, Kenneth, Tendul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Brachytherapy
DOI:
10.1016/j.brachy.2019.10.005
Date:
December, 2019
File:
PDF, 331 KB
2019
Conversion to is in progress
Conversion to is failed